Strategic funding Recovery Force has attracted notable funding from both NIH grants and private angels totaling approximately $11.8M in recent years, signaling strong validation of its Mobile Active Compressions calf device and potential for scaled manufacturing partnerships.

Clinical validation With NIH support and a collaboration history with Mayo Clinic, there is a clear path and credibility for continuing clinical studies and outcomes data, creating opportunities to position RF devices for hospital procurement and reimbursement discussions.

Manufacturing alliance Current engagement with Jabil as a manufacturing partner indicates readiness for scaled production and integrated textile-electronics solutions, suggesting sales opportunities across contract manufacturing services and turnkey supply chain support.

Executive access Recent leadership addition and Midwest base present openings for enterprise sales initiatives targeting hospital networks, home health integration, and value-based care programs where remote monitoring and mobility rehabilitation devices can drive outcomes.

Growth trajectory Revenue already in the low to mid single-digit millions with ongoing fundraising points to an expanding customer footprint; market opportunities exist in hospitals, long-term care facilities, and at-home health programs seeking wearable mobility solutions.